Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

Vaccine

Volumn 22, Issue 25-26, 2004, Pages 3427-3434

  Wesley, Ronald D ^a   Tang, Min ^a   Lager, Kelly M ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Recombinant adenovirus vaccine; Subtype H3N2; Swine influenza virus

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; HEMAGGLUTININ; INFLUENZA VACCINE; MATERNAL ANTIBODY; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; LUNG INJURY; NONHUMAN; NOSE; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROVOCATION TEST; SWINE; SWINE DISEASE; SWINE INFLUENZA VIRUS; VACCINATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; GENETIC VECTORS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LUNG; NASAL MUCOSA; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; PRECIPITIN TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; SWINE DISEASES; VACCINATION; VACCINES, SYNTHETIC; VIRUS SHEDDING;

EID: 4043181266     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.02.040     Document Type: Article

References (40)

1. Webby R.J., Swenson S.L., Krauss S.L., Gerrish P.J., Goyal S.M., Webster R.G. Evolution of swine H3N2 influenza viruses in the United States. J. Virol. 74:2000;8243-8251
2. Olsen C.W. The emergence of novel swine influenza viruses in North America. Virus Res. 85:2002;199-210
3. Rossow K. Swine pathology and diagnosis. Proc. Leman Swine Conf. 26:1999;2-4
4. Easterday BC, Van Reeth K. Swine influenza. In: Straw BE, D'Allaire S, Mengeling WL, Taylor DJ, editors. Diseases of Swine. 8th ed. Ames: Iowa State University Press; 1999. p. 277-90.
5. Brown GB, McMillen JK. MaxiVac™-FLU: evaluation of the safety and efficacy of a swine influenza vaccine. In: Proc Am Assoc Swine Pract. 25th Annual Meeting; 1994. p. 37-9.
6. Janke B.H. Diagnosis of swine influenza. Swine Health Prod. 8(2):2000;79-84
7. Karasin A.I., Olsen C.W., Anderson G.A. Genetic characterization of an H1N2 influenza virus isolated from a pig in Indiana. J. Clin. Microbiol. 38:2000;2453-2456
8. Choi Y.K., Goyal S.M., Joo H.S. Prevalence of swine influenza subtypes on swine farms in the United States. Arch. Virol. 147:2002;1209-1220
9. Lamb RA, Krug RM. Othomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, et al., editors. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1487-531.
10. Andrew M.E., Coupar B.E.H., Boyle D.B., Ada G.L. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J. Immunol. 25:1987;21-28
11. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., et al. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J. Virol. 72:1998;1491-1496
12. Yewdell J.W., Bennink J.R., Smith G.L., Moss B. Influenza A nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 82:1985;1785-1789
13. Wraith D.C., Vessey A.E., Askonas B.A. Purified influenza virus nucleoprotein protects mice from lethal infection. J. Gen. Virol. 68:1987;433-440
14. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749
15. Berkner K.L. Development of adenovirus vectors for the expression of heterologous genes. Biotechniques. 6:1988;616-629
16. Prevec L., Schneider M., Rosenthal K.L., Belbeck L.W., Derbyshire J.B., Graham F.L. Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 70:1989;429-434
17. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW, editor. Vaccines: new approaches to immunological problems. Woburn, MA: Butterworth-Heinemann; 1992. p. 363-90.
18. Grunhaus A., Horwitz M.S. Adenoviruses as cloning vectors. Semin. Virol. 3:1992;237-252
19. Eloit M. Defective adenoviruses as virus vectors for veterinary vaccines. Vet. Res. 26(3):1995;207-208
20. Hitt M.M., Graham F.L. Adenovirus vectors for human gene therapy. Adv. Virus Res. 55:2000;479-505
21. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36:1977;59-74
22. Chengalvala M.V., Bhat B.M., Bhat R., Lubeck M.D., Mitzutani S., Davis A.R., et al. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. J. Gen. Virol. 75:1994;125-131
23. Ambriovic A., Adam M., Monteil M., Paulin D., Eloit M. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells. Virology. 238:1997;327-335
24. Eloit M., Gilardi-Hebenstreit P., Toma B., Perricaudet M. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J. Gen. Virol. 71:1990;2425-2431
25. Konishi E., Pincus S., Paoletti E., Laegreid W.W., Shope R.E., Mason P.W. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology. 190:1992;454-458
26. Brockmeier S.L., Lager K.M., Tartaglia J., Riviere M., Paoletti E., Mengeling W.L. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses. Vet. Microbiol. 38:1993;41-58
27. Potier M.F., Monteil M., Houdayer C., Eloit M. Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies. Vet. Microbiol. 55:1997;75-80
28. Mayr G.A., Chinsangaram J., Grubman M.J. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology. 263:1999;496-506
29. Monteil M., Le Pottier M.F., Ristov A.A., Cariolet R., L'Hospitalier R., Klonjkowski B., et al. Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies. Vaccine. 18:2000;1738-1742
30. Mayr G.A., O'Donnell V., Chinsangaram J., Mason P.W., Grubman M.J. Immune responses and protection against foot-and-mouth disease virus (FMVD) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine. 19:2001;2152-2162
31. Moraes M.P., Mayr G.A., Mason P.W., Grubman M.J. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine. 20:2002;1631-1639
32. Larsen D.L., Karasin A., Olsen C.W. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine. 19:2001;2842-2853
33. Tang M., Harp J.A., Wesley R.D. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Arch. Virol. 147:2002;2125-2141
34. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2509-2514
35. Wesley R.D., Woods R.D. Identification of a 17,000 molecular weight antigenic polypeptide in transmissible gastroenteritis virus-infected cells. J. Gen. Virol. 67:1986;1419-1425
36. Specter S, Lancz GJ. Clinical virology manual. New York: Elsevier; 1986.
37. Mumford JA. Equine Influenza. In: Manual of standards for diagnostic tests and vaccines. OIE: Paris; 1996. p. 409-19.
38. Palmer DF, Dowdle WR, Coleman MT, Schild GC. Advanced laboratory techniques for influenza diagnosis. In: Immunology series no. 6. US Department of Health, Education, and Welfare; 1975. p. 51-2.
39. Webster R.G., Kawaoka Y., Taylor J., Weinberg R., Paoletti E. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine. 9:1991;303-308
40. Prasad S.A., Norbury C.C., Chen W., Bennink J.R., Yewdell J.W. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. J. Immunol. 166:2001;4809-4812